What does a high hepatitis B surface antibody level of 200 mIU/mL mean?
A high level of hepatitis B surface antibody (HBsAb) at over 200 mIU/mL indicates that the body has already produced corresponding protective antibodies. The specific analysis is as follows:
The hepatitis B surface antibody is part of the immune response to the hepatitis B virus surface antigen, typically produced after receiving the hepatitis B vaccine or following infection with the hepatitis B virus. This antibody can neutralize HBsAg in the body, thereby preventing further infection and replication of the hepatitis B virus. When a person receives the hepatitis B vaccine, the surface antigen in the vaccine stimulates the body to produce an antibody response—namely, the hepatitis B surface antibody. If the level of hepatitis B surface antibody is over 200 mIU/mL after vaccination, it indicates that the vaccine has successfully induced effective protective antibodies. If an individual has never been vaccinated against hepatitis B but still shows a hepatitis B surface antibody level above 200 mIU/mL, this suggests a past infection with the hepatitis B virus that has since been cleared, resulting in the production of protective antibodies.
Whether the antibodies were produced through vaccination or as a result of a previous infection, they both provide protective immunity; therefore, there is no need for excessive concern.